These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Some clinical experiences with the arylsulfonylureas in the management of diabetes mellitus. ERK V; HAAR H; MCGAVACK TH; SEEGERS W Metabolism; 1956 Nov; 5(6 Part 2):919-32. PubMed ID: 13378061 [No Abstract] [Full Text] [Related]
5. The mechanism of action of the sulfonylureas in diabetes mellitus. LEVINE R; SOBEL GW Diabetes; 1957; 6(3):263-9. PubMed ID: 13427633 [No Abstract] [Full Text] [Related]
6. Tolbutamide in treatment of diabetes mellitus. BUTTERFIELD WJ; FRY IK; HARDWICK C; HOLLING HE Br Med J; 1957 Aug; 2(5040):325-7. PubMed ID: 13446469 [No Abstract] [Full Text] [Related]
7. Tolbutamide in diabetes; some clinical and biochemical studies. CROWLEY MF; WOLFF FW; BLOOM A Br Med J; 1957 Aug; 2(5040):327-31. PubMed ID: 13446470 [No Abstract] [Full Text] [Related]
8. Current status of aryl sulfonylureas in treatment of diabetes mellitus. DAVIDSON JW; UNGER RH J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329 [No Abstract] [Full Text] [Related]
9. New orally effective adjuvants in the management of diabetes mellitus. O'DONOVAN CJ J Chronic Dis; 1956 Dec; 4(6):635-43. PubMed ID: 13376693 [No Abstract] [Full Text] [Related]
11. Sulfonylureas and diabetes mellitus. I. Clinical evaluation. COX RW; FERGUS EB; HENLEY ED; WILLIAMS RH Diabetes; 1956; 5(5):358-65. PubMed ID: 13365475 [No Abstract] [Full Text] [Related]
12. Present state of knowledge concerning effects of the sulfonylurea compounds in diabetes mellitus; report of the Committee on Summarization of the Conference. KRAHL ME; LUKENS FD; RICKETTS HT Diabetes; 1957; 6(1):91-2. PubMed ID: 13397436 [No Abstract] [Full Text] [Related]
13. Clinical experience and experimental studies with tolbutamide. CRAIG JW; MILLER M Diabetes; 1957; 6(3):280-2; discussion, 282-9. PubMed ID: 13427636 [No Abstract] [Full Text] [Related]
14. The hypoglucemic sulfonylurea drugs; an interim evaluation. STETTEN D Ann Intern Med; 1957 May; 46(5):1005-8. PubMed ID: 13411912 [No Abstract] [Full Text] [Related]
16. Clinical use of oral sulfonylurea compounds in diabetes mellitus. COLWELL AR; COLWELL JA Q Bull Northwest Univ Med Sch; 1957; 31(2):102-13. PubMed ID: 13453644 [No Abstract] [Full Text] [Related]
17. The value of BZ 55 in control of diabetes. MURRAY I; WANG I Br Med J; 1956 Aug; 2(4990):452-4. PubMed ID: 13342512 [No Abstract] [Full Text] [Related]
18. BZ 55 and D 860 in the treatment of diabetes mellitus. SCHNEIDER T; POLITZER WM S Afr Med J; 1957 Feb; 31(7):142-6. PubMed ID: 13409061 [No Abstract] [Full Text] [Related]
19. Studies of the mechanism of action of sulfonylurea derivatives. GOLDNER MG; LAZARUS SS; VOLK BW; WEISENFELD S Diabetes; 1957; 6(1):53-4. PubMed ID: 13397423 [No Abstract] [Full Text] [Related]
20. CARBUTAMIDE and tolbutamide in diabetes. S Afr Med J; 1956 Dec; 30(51):1221-2. PubMed ID: 13391101 [No Abstract] [Full Text] [Related] [Next] [New Search]